InvestorQ : How were the quarterly numbers of Cipla Ltd for the fourth quarter?
Neelam Naik made post

How were the quarterly numbers of Cipla Ltd for the fourth quarter?

Answer
image
Anu Biswas answered.
2 weeks ago
Follow

Cipla reported 14.2% growth in sales for Q4FY22 at Rs5,260 crore with full year revenues growing by 13.6% at Rs21,763 crore. For the fourth quarter, Cipla saw 16% growth in R&D spending. Its now popular One-India initiative saw growth across core therapies at 21%. The North American business saw 17% dollar growth on strong traction across respiratory portfolio and peptide unlocking. API business was down -41% yoy as is the global trend.

Cipla

Rs in Crore

Mar-22

Mar-21

YOY

Dec-21

QOQ

Total Income (Rs cr)

₹ 5,260.33

₹ 4,606.45

14.19%

₹ 5,478.86

-3.99%

Net Profit (Rs cr)

₹ 362.07

₹ 413.38

-12.41%

₹ 728.60

-50.31%

Diluted EPS (Rs)

₹ 4.48

₹ 5.12

₹ 9.02

Net Margins

6.88%

8.97%

13.30%

  

Net profits for Q4FY22 were lower by -12.41% at Rs362 crore even as they managed to achieve a sharp reduction in debt by more than half to Rs824 crore. EBITDA fell -4% at Rs763 crore and EBITDA margins tapered by 279 bps to 14.5%. API business contributed a good deal to the fall in profits in the quarter. Net margins stood at 6.88% in Q4FY22 quarter compared to 8.97% in Q4FY21 and 13.3% in Q3FY22.

2 Views